Skip to main content
Creating Markets for Medical Innovation with Lower Commercial Potential: It's hard, but worth it.
5/14/2019

In the latest edition of the Milken Institute Review, we examine if there could be a thriving market for good science in biopharmaceuticals that has lesser commercial prospects or is simply an ill-fit with corporate strategies. Here, we lay out the basic ingredients required to foster such a market, and describe alternative channels that could unlock the capital needed to leverage the full scope of innovation.

Full Story: